Topic Name

Message

If ARUP Consult does not answer your test selection and interpretation questions, or if you would like to suggest ways to improve content or usability, please send a message to the Consult editorial staff.

Please do not include any patient-specific or personal health information (PHI) in your message.

Email Address

An email address is not required, but providing one allows the ARUP Consult editorial staff to respond directly. ARUP will only use your email address to respond to your feedback. See the ARUP privacy policy for more information regarding email use.

CAPTCHA

What code is in the image?

Enter the characters shown in the image.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

NCCN - genetic/familial high-risk assessment: breast, ovarian, and pancreatic v 2.2021

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: genetic/familial high-risk assessment—breast, ovarian, and pancreatic. Version 2.2021. Updated Nov 2020; accessed Aug 2021.

Feedback

NCCN - genetic/familial high-risk assessment: breast, ovarian, and pancreatic v 2.2021

What links here